AU2473695A - Method of slowing the progression of hiv infection - Google Patents

Method of slowing the progression of hiv infection

Info

Publication number
AU2473695A
AU2473695A AU24736/95A AU2473695A AU2473695A AU 2473695 A AU2473695 A AU 2473695A AU 24736/95 A AU24736/95 A AU 24736/95A AU 2473695 A AU2473695 A AU 2473695A AU 2473695 A AU2473695 A AU 2473695A
Authority
AU
Australia
Prior art keywords
slowing
progression
hiv infection
hiv
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24736/95A
Inventor
MacKenzie Dr. Walser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2473695A publication Critical patent/AU2473695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
AU24736/95A 1994-05-09 1995-05-04 Method of slowing the progression of hiv infection Abandoned AU2473695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23964794A 1994-05-09 1994-05-09
US239647 1994-05-09
PCT/US1995/005662 WO1995030418A1 (en) 1994-05-09 1995-05-04 Method of slowing the progression of hiv infection

Publications (1)

Publication Number Publication Date
AU2473695A true AU2473695A (en) 1995-11-29

Family

ID=22903099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24736/95A Abandoned AU2473695A (en) 1994-05-09 1995-05-04 Method of slowing the progression of hiv infection

Country Status (2)

Country Link
AU (1) AU2473695A (en)
WO (1) WO1995030418A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612990D0 (en) * 1996-06-20 1996-08-21 Stanford Rock Ltd Compositions and methods for the treatment of chronic infections
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
AU2008303942A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of BFGF 1-24 and optionally (ARG 8) vasopressin to treat eg S. pneumoniae infection
WO2009043527A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Therapeutic use of human growth hormone 1-43
AU2008297935A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a RGD-peptide and/or parathyroid hormone (1-34 ) as anti-HIV agent
AU2008297905A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a laminin peptide as a therapeutic agent
EP3858357A1 (en) * 2020-01-28 2021-08-04 Diaccurate Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib

Also Published As

Publication number Publication date
WO1995030418A1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
AU1678295A (en) Hemofiltration and plasmafiltration devices and methods
AU7867994A (en) Hemofiltration of mediator-related diseases
AU7467896A (en) Extra-lumenal crossflow plasmapheresis devices
AU4878096A (en) Hepatitis b vaccine
AU7973994A (en) Combination therapy for hiv infection
AU1285300A (en) Hiv vaccine
AU1408300A (en) Hiv infection inhibitors
AU5758594A (en) Treatment of viral infections
AU2473695A (en) Method of slowing the progression of hiv infection
AU642751B2 (en) New embodiments of the HIV principal neutralizing determinant
AU5568290A (en) Method of suppressing hiv infection
AU1193988A (en) Method of inhibiting the transmission of aids virus
AU2691095A (en) Chlorohydrin process
HRP960045B1 (en) Combination therapy for hiv infection
EP0789565A4 (en) Prevention of hiv infection
AU1538895A (en) Anti-allergic vaccine
AU3553195A (en) Methods of identifying agents which block hiv infection
AU3462193A (en) Polyalkylcyanoacrylate nanocapsules
AU2924895A (en) Anti-hiv triple combination
AU3530395A (en) Treatment of viral infections
ZA955269B (en) Combination therapy for HIV infection
AU8934691A (en) Pressure converter
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
AU2414992A (en) Method of combatting hiv infections
AU3250495A (en) Weir